Suppr超能文献

无近期加重史个体慢性阻塞性肺疾病加重的危险因素:COPDGene 分析。

Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.

机构信息

Division of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Department of Biostatistics and.

出版信息

Ann Am Thorac Soc. 2024 Mar;21(3):421-427. doi: 10.1513/AnnalsATS.202209-751OC.

Abstract

Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are detrimental events in the natural history of COPD, but the risk factors associated with future exacerbations in the absence of a history of recent exacerbations are not fully understood. To identify risk factors for COPD exacerbations among participants in the Genetic Epidemiology of COPD Study (COPDGene) without a history of exacerbation in the previous year. We identified participants with a smoking history enrolled in COPDGene who had COPD (defined as forced expiratory volume in 1 second [FEV]/forced vital capacity < 0.70), no exacerbation in the year before their second study site visit, and who completed at least one longitudinal follow-up questionnaire in the following 36 months. We used univariable and multivariable zero-inflated negative binomial regression models to identify risk factors associated with increased rates of exacerbation. Each risk factor's regression coefficient (β) was rounded to the nearest 0.25 and incorporated into a graduated risk score. Among the 1,528 participants with a smoking history and COPD enrolled in COPDGene without exacerbation in the year before their second study site visit, 508 participants (33.2%) had at least one moderate or severe exacerbation in the 36 months studied. Gastroesophageal reflux disease, chronic bronchitis, high symptom burden (as measured by Modified Medical Research Council Dyspnea Scale and COPD Assessment Test), and lower FEV% predicted were associated with an increased risk of exacerbation. Each 1-point increase in our graduated risk score was associated with a 25-30% increase in exacerbation rate in the 36 months studied. In patients with COPD without a recent history of exacerbations, gastroesophageal reflux disease, chronic bronchitis, high symptom burden, and lower lung function are associated with increased risk of future exacerbation using a simple risk score that can be used in clinical practice.

摘要

慢性阻塞性肺疾病(COPD)的急性加重(AE-COPD)是 COPD 自然病程中的不利事件,但对于没有近期加重史的患者,与未来加重相关的危险因素尚不完全清楚。本研究旨在确定 COPD 基因研究(COPDGene)中既往 1 年无加重史的患者发生 COPD 加重的危险因素。

我们确定了 COPDGene 研究中具有吸烟史且符合以下条件的参与者:用力呼气量 1 秒(FEV1)/用力肺活量(FVC)<0.70 定义为 COPD,在第二次研究访视前 1 年内无加重史,且在随后的 36 个月内至少完成 1 次纵向随访问卷。我们采用单变量和多变量零膨胀负二项回归模型来确定与加重率增加相关的危险因素。每个危险因素的回归系数(β)四舍五入到最接近的 0.25,并纳入分级风险评分。

在 COPDGene 中,1528 名有吸烟史且符合 COPD 诊断标准且在第二次研究访视前 1 年内无加重史的患者中,508 名(33.2%)患者在研究的 36 个月内至少发生了 1 次中重度加重。胃食管反流病、慢性支气管炎、高症状负担(采用改良医学研究理事会呼吸困难量表和 COPD 评估测试进行评估)和较低的 FEV1%预计值与加重风险增加相关。我们的分级风险评分每增加 1 分,在研究的 36 个月内,加重率增加 25-30%。

在既往无近期加重史的 COPD 患者中,胃食管反流病、慢性支气管炎、高症状负担和较低的肺功能与未来加重风险增加相关,可使用简单的风险评分进行评估,该评分可用于临床实践。

相似文献

2
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.
3
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
4
Predicting exacerbations in COPD in the Danish general population.
Respir Med. 2024 Apr;224:107557. doi: 10.1016/j.rmed.2024.107557. Epub 2024 Feb 13.
6
Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.
Am J Respir Crit Care Med. 2017 Feb 15;195(4):473-481. doi: 10.1164/rccm.201607-1330OC.
8
Comparing Heterogenous Phenotypes of Chronic Obstructive Pulmonary Disease: Network Analysis and Penalized Generalized Linear Model.
Int J Chron Obstruct Pulmon Dis. 2025 Apr 28;20:1267-1277. doi: 10.2147/COPD.S496199. eCollection 2025.
9
The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
Int J Chron Obstruct Pulmon Dis. 2015 Oct 28;10:2327-34. doi: 10.2147/COPD.S91362. eCollection 2015.
10
Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease.
Dis Esophagus. 2013 Aug;26(6):557-60. doi: 10.1111/dote.12014. Epub 2013 Jan 10.

引用本文的文献

1
Association of gastroesophageal reflux disease with the incidence of pulmonary disease.
Front Cell Dev Biol. 2025 Jul 23;13:1552126. doi: 10.3389/fcell.2025.1552126. eCollection 2025.
2
Characteristics and actions in high-risk COPD in unstable patients: The EPOCONSUL audit.
PLoS One. 2025 Jul 18;20(7):e0327775. doi: 10.1371/journal.pone.0327775. eCollection 2025.
3
Identifying central symptom clusters and correlates among post-COVID-19 pulmonary fibrosis patients: a network analysis.
Front Med (Lausanne). 2025 May 21;12:1538708. doi: 10.3389/fmed.2025.1538708. eCollection 2025.
4
Treatable traits identified in Chinese patients hospitalized with AECOPD: A Multicenter Cohort Study.
Int J Med Sci. 2025 Apr 13;22(9):2227-2236. doi: 10.7150/ijms.111294. eCollection 2025.
5
Predicting Chronic Obstructive Pulmonary Disease Exacerbations: When the Past Does Not Inform the Future.
Ann Am Thorac Soc. 2024 Mar;21(3):382-383. doi: 10.1513/AnnalsATS.202311-934ED.

本文引用的文献

1
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
N Engl J Med. 2022 Sep 29;387(13):1173-1184. doi: 10.1056/NEJMoa2204752. Epub 2022 Sep 4.
2
Effectiveness of Proton-Pump Inhibitors in Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials.
Front Med (Lausanne). 2022 Feb 16;9:841155. doi: 10.3389/fmed.2022.841155. eCollection 2022.
4
Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review.
JAMA. 2019 Feb 26;321(8):786-797. doi: 10.1001/jama.2019.0131.
5
Which Physicians Are Taking Care of People With COPD?
Chest. 2019 Apr;155(4):771-777. doi: 10.1016/j.chest.2018.12.018. Epub 2019 Jan 18.
6
Mortality in the United States, 2016.
NCHS Data Brief. 2017 Dec(293):1-8.
8
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.
9
Why Don't Our Patients with Chronic Obstructive Pulmonary Disease Listen to Us? The Enigma of Nonadherence.
Ann Am Thorac Soc. 2016 Mar;13(3):317-23. doi: 10.1513/AnnalsATS.201509-600PS.
10
Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
Am J Respir Crit Care Med. 2016 May 1;193(9):965-74. doi: 10.1164/rccm.201509-1869OC.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验